MAIOLI, SARA
MAIOLI, SARA
Dipartimento di Scienze Cliniche e di Comunità
Autosomal Dominant Hyper-IgE Syndrome Patients Retain IL10-Producing preTh17-Cells That Are Activated by Opportunistic Pathogens and Support IgE Production
2026 G. Moschetti, C. Vasco, F. Clemente, P. Larghi, S. Maioli, E. Scarpa, E. Carelli, N. Pulvirenti, M. Lucia Sarnicola, M. Crosti, M. Bel Imam, W. Van De Veen, L. Rizzello, S. Abrignani, L. A Baselli, R. Maria Dellepiane, M. Carrabba, G. Fabio, J. Geginat
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas
2025 E. Esposito, G. Marra, R. Catalano, S. Maioli, E. Nozza, A.M. Barbieri, C. Hantel, G. Di Dalmazi, S. Sigala, J. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, A. Berruti, E. Ferrante, G. Mantovani, E. Peverelli
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas
2024 E. Esposito/, R. Catalano, E. Nozza, G. Marra, S. Maioli, G. Dimuro, A.M. Barbieri, H. Constanze, G. Didalmazi, J.E. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, E. Ferrante, G. Mantovani, E. Peverelli
Alemtuzumab-induced thyroid eye disease successfully treated with a single low-dose of rituximab
2024 I. Muller, S. Maioli, M. Armenti, L. Porcaro, N. Currò, E. Iofrida, L. Pignataro, J. Manso, C. Mian, J. Geginat, M. Salvi
Long-term outcome of thyroid abnormalities in patients with severe Covid-19
2023 I. Muller, A. Daturi, M. Varallo, T.E. Re, D. Dazzi, S. Maioli, E. Crivicich, F. Di Marco, V. Longari, B. Dazzi, M. Castellani, G. Mantovani, M. Arosio, M. Salvi
SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype
2023 Y. Silvestri, F. Clemente, G. Moschetti, S. Maioli, E. Carelli, A. Espadas de Arias, R. Torelli, E. Longhi, T. De Feo, M. Crosti, M.L. Sarnicola, M. Salvi, G. Mantovani, M. Arosio, M. Bombaci, E. Pesce, R. Grifantini, S. Abrignani, J. Geginat, I. Muller